Jeanie Tryggestad

Director of the Turner Syndrome Clinic · Oklahoma Children's Hospital

Credentials: · · ·

History

The Oklahoma Pediatric Clinical Trials Network
NIH Office of the Director · UG1
PI · $2.3M · University of Oklahoma Hlth Sciences Ctr
2016–2030
Identifying Metabolic and Psychosocial Antecedents and Characteristics of Youth-Onset Type 2 Diabetes (IMPACT DM)
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $2.1M · University of Oklahoma Hlth Sciences Ctr
2023–2029
Impact of in utero Diabetes Exposure on miRNA: Effects on Cellular Metabolism
National Institute of Diabetes and Digestive and Kidney Diseases · R03
Contact PI · $189K · University of Oklahoma Hlth Sciences Ctr
2021–2024
In utero Exposure to Diabetes and Future Cardiometabolic Risk: The Role of miRNA
National Institute of Diabetes and Digestive and Kidney Diseases · K23
Contact PI · $638.1K · University of Oklahoma Hlth Sciences Ctr
2016–2021

CEP249 Pediatric Accuracy Study
Principal investigator · Completed
Medtronic MiniMed, Inc.
2015–2016
TODAY2 Phase 2 Follow-up
Principal investigator · Completed
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
2014–2020
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Site PI · Not yet recruiting · Phase 3
Eli Lilly and Company
2026–2032
Phentermine's Impact on Treatment in Teens
Site PI · Recruiting · Phase 2
Russell McCulloh, MD
2026–2028